Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 34.2 -0.52 (-1.5%) Market Cap: 1.95 Bil Enterprise Value: 1.75 Bil PE Ratio: 16.21 PB Ratio: 3.27 GF Score: 65/100

Harmony Biosciences Holdings Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 11, 2022 / 04:45PM GMT
Release Date Price: $47.15 (-5.30%)
Ami Fadia
Needham & Company, LLC - Analyst

Good afternoon, everyone. Thank you for joining us today, and it's my pleasure to be hosting Harmony Bioscience. I have with me Jeff Jacobs (sic - "John Jacobs"), President and CEO of the company; and Sandip Kapadia, who is the CFO.

Questions & Answers

Ami Fadia
Needham & Company, LLC - Analyst

Let me just start by kicking off with a question for John.

John Jacobs
Harmony Biosciences Holdings, Inc. - President & CEO

Thank you, Ami.

Ami Fadia
Needham & Company, LLC - Analyst

John, thank you for joining us today. Perhaps I could start by asking you a broad question. We are past the 18-month mark and closing into about two years since the company IPOed.

John Jacobs
Harmony Biosciences Holdings, Inc. - President & CEO

It's hard to believe, yeah.

Ami Fadia
Needham & Company, LLC - Analyst

Exactly. What

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot